CCL3, also known as MIP1A, is a chemokine secreted by MM cells [34]; high levels of MIP1A in MM cells and the serum of MM patients correlate with the severity of bone disease as well as with worse prognosis [35]. Here, CCL3 is linked to Miyoshi myopathy.